Accession Number: | 0001127602-20-015829 |
Date: | 2020-05-05 |
Issuer: | GILEAD SCIENCES INC (GILD) |
Original Submission Date: |
WILSON GAYLE E
GILEAD SCIENCES, INC.
333 LAKESIDE DRIVE
FOSTER CITY, CA 94404
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-05-05 | M | 2,270 | a | $0.00 | 129,052 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
RESTRICTED STOCK UNIT | 0.0 | 2020-05-05 | deemed execution date | M | 2,270 (d) | common stock 2,270 | $0.00 | 0 | direct |
ID | footnote |
---|---|
f1 | each restricted stock unit represents the contingent right to receive one share of gilead sciences, inc.'s common stock. |
f2 | 100% of the restricted stock units vested on may 5, 2020. |